KR890014101A - 동맥경화증 치료제 - Google Patents

동맥경화증 치료제 Download PDF

Info

Publication number
KR890014101A
KR890014101A KR1019890003642A KR890003642A KR890014101A KR 890014101 A KR890014101 A KR 890014101A KR 1019890003642 A KR1019890003642 A KR 1019890003642A KR 890003642 A KR890003642 A KR 890003642A KR 890014101 A KR890014101 A KR 890014101A
Authority
KR
South Korea
Prior art keywords
atherosclerosis treatment
group
atherosclerosis
treatment
integers
Prior art date
Application number
KR1019890003642A
Other languages
English (en)
Inventor
도시히꼬 이시미쯔
호로아끼 마쯔오까
쯔네아끼 스기모또
마사오 이시이
도모오 시오자와
Original Assignee
원본미기재
다이이찌 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 다이이찌 세이야꾸 가부시끼가이샤 filed Critical 원본미기재
Publication of KR890014101A publication Critical patent/KR890014101A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음.

Description

동맥경화증 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 활성성분으로서 일반식(I) 의 화합물 또는 이의 염을 함유하는 동맥경화증 치료제.
    상기식에서, R은 이미다졸일 그룹, 티아졸일 그룹, 또는 피리딜 그룹을 나타내고, n은 1또는 2를 나타내며, m은 1내지 4중 한 정수를 나탄낸다.
    ※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
KR1019890003642A 1988-03-24 1989-03-23 동맥경화증 치료제 KR890014101A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7045388 1988-03-24
JP63-70453 1988-03-24

Publications (1)

Publication Number Publication Date
KR890014101A true KR890014101A (ko) 1989-10-21

Family

ID=13431941

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890003642A KR890014101A (ko) 1988-03-24 1989-03-23 동맥경화증 치료제

Country Status (5)

Country Link
EP (1) EP0334369B1 (ko)
KR (1) KR890014101A (ko)
AU (1) AU614589B2 (ko)
CA (1) CA1334380C (ko)
DE (1) DE68907244T2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657058B1 (fr) * 1990-01-18 1994-10-21 Peugeot Dispositif de commande manuelle du frein de stationnement d'un vehicule automobile.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61191612A (ja) * 1985-02-20 1986-08-26 Dai Ichi Seiyaku Co Ltd 虚血性心疾患用剤

Also Published As

Publication number Publication date
EP0334369B1 (en) 1993-06-23
DE68907244T2 (de) 1993-10-07
AU3171289A (en) 1989-09-28
EP0334369A3 (en) 1990-10-10
CA1334380C (en) 1995-02-14
EP0334369A2 (en) 1989-09-27
AU614589B2 (en) 1991-09-05
DE68907244D1 (de) 1993-07-29

Similar Documents

Publication Publication Date Title
DE58906847D1 (de) Stabilisierte wässrige Lösungen von 3-Isothiazolinonen.
DE3783683D1 (de) Hautpenetration verbessernde zusammensetzungen.
KR910000104A (ko) 투명 조성물
KR900002700A (ko) 살균제 조성물
KR870005968A (ko) 아미드 유도체 및 이를 함유하는 외용약제
KR910021361A (ko) 항궤양 물질
KR890001540A (ko) 심부전증 치료제
KR880002822A (ko) 뇌허혈증 예방 치료제
KR890014101A (ko) 동맥경화증 치료제
KR890012642A (ko) 타닌산의 떫은 맛 및 쓴 맛의 감소 방법
KR900701262A (ko) 췌장염 등에 대한 치료제
KR920019364A (ko) 약학적 화합물
KR910000148A (ko) 말초순환 장애용 치료제
KR960702458A (ko) 퀴놀린 유도체 또는 그의 염 및 이를 함유 하는 항균제
KR890016027A (ko) 벤즈티아졸 살진균제
KR890009270A (ko) 식물 보호용 살균제
KR910000115A (ko) 멜라닌 생성 억제 외용제
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR920016021A (ko) 동물의 발육 촉진 또는 개선 사료 및 방법
KR880012228A (ko) 천식 치료제
KR870003788A (ko) 모발자극 화합물
KR880006177A (ko) 구아니디노 메틸벤조산 유도체
KR900003201A (ko) 펩티드 및 항치매제
KR920000327A (ko) 비스(3,5-디-알킬-4- 히드록시페닐티오) 메탄을 유효 성분으로 함유하는 고트리글리세리드혈증 치료용 제약 조성물
KR850000464A (ko) 살충제 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application